Many congratulations to Dr Rasha Abu Eid (Institute of Dentistry) and Dr Frank Ward (Institute of Medical Sciences) on their publication in Immunology Letters "Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients".
Dr Rasha Abu-Eid (Institute of Dentistry) and Dr Frank Ward (Institute of Medical Sciences) built on their expertise in modulating the immune response to propose a therapeutic strategy in COVID-19 patients. This review published in Immunology Letters suggests that inhibiting different targets in the essential PI3K/Akt/mTOR signalling pathway has the potential to modulate the immune response to COVID-19, prevent blood clot formation, and reduce the SARS-cov-2 viral load.
Dr Abu-Eid and Dr Ward received funding from Friends of ANCHOR to study the effect of targeting the PI3K/Akt/mTOR pathway to modulate the immune response in COVID-19 ( RS 2019 004) and from Medical Research Scotland to assess methods for reducing the risk of SARS-cov2 associated cytokine storms in COVID-19 patients (COVID-19 Research Grant).
To access the publication, please follow the link below: